Unlocking the 280E Maze: Strategic Cost Allocation Methods That Are Saving Cannabis Operators Millions

For most American businesses, the ability to deduct ordinary operating expenses from taxable income is so fundamental that it barely warrants a second thought. Payroll, rent, marketing, utilities—these costs reduce a company's taxable income as a matter of course. For legal cannabis operators, however, that assumption is dangerously wrong. Section 280E of the Internal Revenue Code effectively strips cannabis businesses of this foundational tax benefit, creating an effective tax burden that can reach 70 percent or more of gross profit. The consequences ripple across the entire supply chain, from licensed cultivators to wholesale distributors to storefront retailers.

Yet the situation is not entirely without remedy. Across the country, operators who have invested in rigorous tax planning are uncovering legally defensible deductions that their competitors are leaving on the table—sometimes to the tune of hundreds of thousands of dollars annually.

What 280E Actually Says—and What It Doesn't

Enacted in 1982 following a court ruling that allowed a cocaine trafficker to deduct business expenses, Section 280E prohibits any deduction or credit for expenses incurred in the trade or business of trafficking a controlled substance under Schedule I or II of the Controlled Substances Act. Because cannabis remains federally classified as a Schedule I substance, all state-licensed cannabis businesses fall squarely within 280E's reach—regardless of whether they operate in full compliance with state law.

What 280E does not prohibit, however, is the deduction of Cost of Goods Sold (COGS). This distinction is the cornerstone of every legitimate 280E mitigation strategy. COGS represents the direct costs of producing or acquiring the goods a business sells, and under IRS regulations, it is treated as a reduction in gross receipts rather than a deductible expense. The practical implication: the more costs a cannabis business can legitimately classify as COGS rather than operating expenses, the lower its taxable income.

The COGS Opportunity: Where Operators Are Finding Relief

For cannabis cultivators and manufacturers, the COGS calculation can be surprisingly expansive. Direct production costs—seeds, growing media, nutrients, direct labor on the cultivation floor, packaging materials used in production, and depreciation on production equipment—all qualify. Indirect production costs, including facility utilities allocated to production space, quality control testing, and a proportionate share of supervisory wages, may also be includable under IRS inventory capitalization rules.

Consider a mid-sized Colorado cultivator that underwent a comprehensive COGS analysis after years of treating its tax situation as a fixed cost. By working with a cannabis-specialized CPA firm, the operator discovered that it had been classifying a significant portion of its master grower's compensation as a general and administrative expense rather than a direct production cost. Reclassifying that compensation—along with utility costs attributable to the grow facility—added over $340,000 to its COGS calculation in a single tax year, generating a meaningful reduction in its federal tax liability.

For cannabis retailers, the COGS opportunity is narrower but still meaningful. A retailer's COGS is generally limited to the acquisition cost of the inventory it purchases for resale, including freight-in and certain handling costs. This is one reason why the pricing and invoicing practices between wholesale suppliers and retail buyers matter enormously from a tax perspective. Suppliers who structure their wholesale agreements to include certain handling and delivery costs within the product price—rather than as separate line-item fees—may be helping their retail partners maximize their COGS deductions.

Business Structuring: The Dual-Entity Approach

Beyond COGS maximization, a number of operators have adopted a dual-entity business structure as a longer-term 280E mitigation strategy. Under this approach, a cannabis business separates its licensed cannabis operations from ancillary, non-cannabis business activities into distinct legal entities. The non-cannabis entity—which might provide management services, real estate leasing, or retail services for non-cannabis products—is not subject to 280E and can deduct its ordinary operating expenses in the normal fashion.

A retail operator in California, for example, restructured its operations so that its licensed dispensary entity handled only cannabis sales, while a separate affiliated company managed the retail space and provided wellness consulting services for non-cannabis products. The ancillary entity was able to deduct its allocated share of rent, staffing, and marketing costs, meaningfully reducing the combined tax burden of the enterprise.

It is worth emphasizing that the IRS scrutinizes these arrangements carefully. For a dual-entity structure to withstand audit, the separation must be substantive, not cosmetic. Each entity must have a genuine, independent business purpose, maintain separate books and records, and conduct arm's-length transactions with its affiliated counterpart. Operators who implement these structures purely as paper arrangements—without actual operational separation—face significant audit risk and potential penalties.

The Audit Risk Reality

The IRS has demonstrated a clear and consistent interest in cannabis business tax filings. Audit rates for cannabis businesses run substantially higher than for comparable businesses in other industries, and examiners have become increasingly sophisticated in identifying 280E-related misreporting. Common audit triggers include COGS figures that appear disproportionately high relative to industry benchmarks, poorly documented cost allocation methodologies, and dual-entity structures that lack genuine business substance.

For operators across the supply chain, the lesson is clear: 280E planning is not a set-it-and-forget-it exercise. It requires ongoing documentation, consistent application of cost allocation methodologies, and regular review by tax professionals who specialize in cannabis industry compliance. A COGS methodology that is implemented correctly but documented poorly is nearly as problematic as one that is implemented incorrectly.

What the Legislative Horizon Means for Planning Decisions

The potential rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act has generated significant discussion about 280E's future. A Schedule III classification would, under the plain language of the statute, remove cannabis businesses from 280E's scope entirely—a development that would fundamentally alter the financial calculus for every operator in the legal market.

However, rescheduling remains far from certain, and the timeline for any formal regulatory change is unclear. Cannabis operators would be ill-advised to defer tax planning on the assumption that legislative or regulatory relief is imminent. Businesses that have invested in rigorous 280E compliance and cost allocation strategies will be well-positioned regardless of how the regulatory landscape evolves—and those that have not may find themselves facing years of back taxes, interest, and penalties if their current practices fail to survive IRS scrutiny.

Building 280E Resilience Into Your Business Model

For suppliers, distributors, and retailers operating within the legal cannabis market, 280E is not merely a tax problem—it is a structural business challenge that demands the same level of strategic attention as pricing, logistics, or licensing compliance. The operators who are navigating it most effectively share several common characteristics: they work with tax advisors who have deep, cannabis-specific expertise; they invest in accounting systems capable of tracking and allocating costs at a granular level; and they treat their cost allocation methodologies as living documents that are reviewed and updated as their businesses evolve.

In an industry where margins are already compressed by licensing fees, regulatory compliance costs, and intense market competition, the difference between a well-executed 280E strategy and a poorly executed one can determine whether a business thrives or merely survives. For operators who have not yet conducted a formal 280E analysis, the question is not whether they can afford to do so—it is whether they can afford not to.